What is Suki?
Suki is a specialized technology enterprise focused on the development of AI-driven voice interfaces designed specifically for the healthcare industry. By integrating seamlessly into the existing healthcare technology stack, Suki provides an invisible, assistive layer that automates documentation and administrative tasks. This approach allows medical professionals to prioritize patient care over manual data entry, effectively reimagining the operational efficiency of modern clinical environments. The company's market position is defined by its commitment to reducing physician burnout through sophisticated machine learning and natural language processing applications.
How much funding has Suki raised?
Suki has raised a total of $161.6M across 5 funding rounds:
Series A
$15M
Series B
$20M
Debt
$1.6M
Series C
$55M
Series D
$70M
Series A (2018): $15M with participation from First Round Capital, Social Capital, and Venrock
Series B (2020): $20M led by Venrock, Breyer Capital, Flare Capital Partners, First Round Capital, and Epsilon Health
Debt (2021): $1.6M supported by PPP
Series C (2021): $55M featuring Philip Ventures, Breyer Capital, Flare Capital Partners, March Capital, Venrock, and inHealth Ventures
Series D (2024): $70M backed by Venrock, Hedosophia, Breyer Capital, and March Capital
Key Investors in Suki
Venrock
Founded in 1969, Venrock is a historic venture capital firm based in Palo Alto that partners with founders to build high-growth technology and healthcare ventures.
Breyer Capital
An independent global venture capital firm founded by Jim Breyer, focusing on long-term, idea-driven investments in AI, machine learning, and consumer software.
Flare Capital Partners
A leading investment firm dedicated exclusively to healthcare technology, collaborating with entrepreneurs to enhance clinical outcomes and reduce industry costs.
What's next for Suki?
Following the latest capital injection, Suki is well-positioned to scale its enterprise operations and expand its footprint within the global healthcare market. The strategic focus will likely center on deepening the integration of its AI capabilities across diverse clinical specialties and enhancing the platform's interoperability with major electronic health record systems. By leveraging the expertise of its long-term backers, Suki aims to solidify its role as a mission-critical infrastructure provider, driving the next wave of digital transformation in medical practice management and administrative automation.
See full Suki company page
